Introduction
Highly active antiretroviral therapy (HAART) has significantly reduced the incidence of severe human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND). However, mild forms persist and nearly 50% of patients have neurocognitive dysfunction despite adequate viral suppression (Heaton et al., 2011) . HIV encephalitis is still seen on autopsy in HAART-treated patients, suggesting that HAART is ineffective in eliminating central nervous system (CNS) infection (Anthony et al., 2005; Langford et al., 2003) .
Viral proteins, such as Tat and gp120, have been implicated in the neurotoxicity of HAND by multiple mechanisms, prominent among which is production of glutamate excitotoxicity. Tat's production is not impacted by available antiretroviral drugs once proviral DNA has been formed. Tat is a potent excitotoxin and is known to stimulate NMDA receptors via direct cysteine-cysteine interactions with the extracellular domains of the receptor (Li et al., 2008; Prendergast et al., 2002) . Tat also promotes the phosphorylation of the NMDA receptor leading to its further stimulation (Haughey et al., 2001) . Tat sensitizes neurons so that normally physiological levels of glutamate cause significant excitotoxicity and massive derangement in intracellular calcium (Nath et al., 2000) and intra-hippocampal Tat administration in rats promotes learning deficits following alcohol withdrawal that is NMDA receptor-dependent (Self et al., 2009) .
While investigating the interactions between Tat and the NMDA receptor, we discovered that some anti-Tat antibodies not only block the neurotoxicity of Tat but also block toxicity of other excitotoxins.
Materials and methods

Tat
Recombinant Tat 1-72 , Tat 1-101 , and mutant Tat Δ31-61 was produced in our laboratory. Details of Tat production and purification have been published (Ma and Nath, 1997; Turchan et al., 2001) . It was greater Neurobiology of Disease 49 (2013) [169] [170] [171] [172] [173] [174] [175] [176] 
